Thyroid Cancer New Drug: Selpercatinib in RET-mutant Medullary Thyroid Cancer Ulas D. Bayraktar, MD 2023-11-20
Nervous System Tumor Thyroid Cancer New Indication: Dabrafenib and Trametinib in bRAV V600E Mutant Anaplastic Thyroid Cancer Ulas D. Bayraktar, MD 2022-09-20
